Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kosuke BANDO"'
Publikováno v:
Journal of Fluid Science and Technology, Vol 6, Iss 5, Pp 754-764 (2011)
At the initial stage of liquid injection into a gas, the injection liquid has not yet been broken up, and at a low surrounding pressure of less than about 0.1 MPa, the tip of the injection liquid forms the shape of a thin string. This phenomenon and
Externí odkaz:
https://doaj.org/article/a03f81e0e7f549f993d362b27b1dac40
Autor:
Kosuke Bando, Yasuhiko Takegami, Toshihiro Ando, Takayuki Sugino, Toshifumi Sato, Tomoki Fujita, Shiro Imagama
Publikováno v:
Journal of Orthopaedic Science. 28:651-655
Open reduction and internal fixation (ORIF) for unstable ankle fractures (AF) are relatively predictable with excellent outcomes. Rehabilitation strategies are still being debated after surgical intervention for AF: non-weight bearing and cast immobi
Autor:
Toshifumi Sato, Kosuke Bando, Shiro Imagama, Takayuki Sugino, Yasuhiko Takegami, Tomoki Fujita
Publikováno v:
Injury. 52:1959-1963
Introduction One of the complications of the surgical therapy for ankle fractures includes wound infection. This study aimed to evaluate postoperative function and clarify the risk factors associated with postoperative wound infection in patients rec
Autor:
Takayuki Sugino, Yasuhiko Takegami, Kosuke Bando, Toshifumi Sato, Tomoki Fujita, Yoshiharu Oka, Shiro Imagama
Publikováno v:
Foot & Ankle Specialist. :193864002311642
Background The present study aimed to evaluate the hypothesis that a 1-week extension of the waiting period to perform surgery for ankle fracture might affect postoperative results and complications. Methods We used our multicenter database named TRO
Autor:
Shuji Terai, Mitsuru Okada, Kosuke Bando, Masayuki Kurosaki, Yasuhiko Fukuta, Moriyoshi Yasuda, Isao Sakaida
Publikováno v:
Hepatology Research. 47:1137-1146
Aim Loop diuretics and spironolactone are used in patients with hepatic edema, but they are sometimes associated with insufficient responses as well as adverse events. Tolvaptan, a vasopressin type 2 receptor antagonist, was approved for hepatic edem
Autor:
Koichiro Kinugawa, Kosuke Bando, Yasuhiko Fukuta, Takayuki Inomata, Toshiyuki Shimakawa, Naoki Sato, Moriyoshi Yasuda
Publikováno v:
International Heart Journal. 58:30-35
The vasopressin receptor 2 (V2) receptor antagonist tolvaptan is an aquaretic agent that has been approved for heart failure patients with volume overload in Japan. In this study (SMILE study), we investigated patient characteristics and effectivenes
Autor:
Isao, Sakaida, Shuji, Terai, Masayuki, Kurosaki, Moriyoshi, Yasuda, Mitsuru, Okada, Kosuke, Bando, Yasuhiko, Fukuta
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 47(11)
Loop diuretics and spironolactone are used in patients with hepatic edema, but they are sometimes associated with insufficient responses as well as adverse events. Tolvaptan, a vasopressin type 2 receptor antagonist, was approved for hepatic edema in
Publikováno v:
Journal of Fluid Science and Technology, Vol 6, Iss 5, Pp 754-764 (2011)
At the initial stage of liquid injection into a gas, the injection liquid has not yet been broken up, and at a low surrounding pressure of less than about 0.1 MPa, the tip of the injection liquid forms the shape of a thin string. This phenomenon and
Autor:
Koichiro Kinugawa, Kosuke Bando, Moriyoshi Yasuda, Takayuki Inomata, Kazuki Mizuguchi, Naoki Sato, Toshiyuki Shimakawa
Publikováno v:
International heart journal. 56(2)
The vasopressin receptor 2 (V2) receptor antagonist tolvaptan is an aquaretic agent that has been found to improve symptoms in patients with congestive heart failure. In this study (SMILE study), we administered tolvaptan to patients aged ≥ 80 year
Autor:
Kosuke Bando, Takayuki Inomata, Naoki Sato, Kazuki Mizuguchi, Moriyoshi Yasuda, Toshiyuki Shimakawa, Koichiro Kinugawa
Publikováno v:
International Heart Journal. 56:581-581